A detailed history of Wealth Alliance Advisory Group, LLC transactions in Novartis Ag stock. As of the latest transaction made, Wealth Alliance Advisory Group, LLC holds 2,800 shares of NVS stock, worth $306,208. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,800
Previous 2,800 -0.0%
Holding current value
$306,208
Previous $298,000 8.05%
% of portfolio
0.07%
Previous 0.07%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$92.57 - $107.37 $18,514 - $21,474
200 Added 7.69%
2,800 $298,000
Q2 2023

Jul 13, 2023

SELL
$92.52 - $104.91 $19,429 - $22,031
-210 Reduced 7.47%
2,600 $262,000
Q4 2022

Jan 17, 2023

BUY
$75.55 - $92.52 $679 - $832
9 Added 0.32%
2,810 $0
Q2 2022

Jul 08, 2022

SELL
$80.52 - $93.75 $5,716 - $6,656
-71 Reduced 2.47%
2,801 $237,000
Q1 2022

Apr 18, 2022

SELL
$80.11 - $90.62 $640 - $724
-8 Reduced 0.28%
2,872 $252,000
Q4 2021

Jan 13, 2022

SELL
$79.7 - $88.13 $2,948 - $3,260
-37 Reduced 1.27%
2,880 $252,000
Q2 2021

Jul 13, 2021

SELL
$85.24 - $94.15 $426 - $470
-5 Reduced 0.17%
2,917 $266,000
Q1 2021

Apr 28, 2021

BUY
$83.5 - $98.47 $2,922 - $3,446
35 Added 1.21%
2,922 $250,000
Q4 2020

Jan 25, 2021

SELL
$78.07 - $94.43 $11,476 - $13,881
-147 Reduced 4.85%
2,887 $273,000
Q3 2020

Oct 08, 2020

SELL
$82.14 - $91.0 $1,807 - $2,002
-22 Reduced 0.72%
3,034 $264,000
Q2 2020

Jul 08, 2020

BUY
$80.93 - $91.1 $809 - $911
10 Added 0.33%
3,056 $267,000
Q1 2020

Apr 15, 2020

BUY
$70.67 - $99.01 $9,893 - $13,861
140 Added 4.82%
3,046 $251,000
Q4 2019

Jan 24, 2020

SELL
$84.35 - $95.37 $4,723 - $5,340
-56 Reduced 1.89%
2,906 $275,000
Q3 2019

Nov 01, 2019

BUY
$85.54 - $94.26 $35,328 - $38,929
413 Added 16.2%
2,962 $257,000
Q1 2019

May 14, 2019

SELL
$75.32 - $86.15 $4,669 - $5,341
-62 Reduced 2.37%
2,549 $207,000
Q4 2018

Jan 28, 2019

BUY
$73.66 - $82.02 $192,326 - $214,154
2,611 New
2,611 $224,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $235B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Wealth Alliance Advisory Group, LLC Portfolio

Follow Wealth Alliance Advisory Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Alliance Advisory Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Alliance Advisory Group, LLC with notifications on news.